Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) - PubMed (original) (raw)

. 2012 Jun;55(6):1577-96.

doi: 10.1007/s00125-012-2534-0. Epub 2012 Apr 20.

Affiliations

• PMID: 22526604
• DOI: 10.1007/s00125-012-2534-0

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

S E Inzucchi et al. Diabetologia. 2012 Jun.

Erratum in

• Diabetologia. 2013 Mar;56(3):680

No abstract available

PubMed Disclaimer

Similar articles

• Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
  Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Inzucchi SE, et al. Diabetologia. 2015 Mar;58(3):429-42. doi: 10.1007/s00125-014-3460-0. Epub 2015 Jan 13. Diabetologia. 2015. PMID: 25583541 No abstract available.
• Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
  Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Inzucchi SE, et al. Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19. Diabetes Care. 2012. PMID: 22517736 Free PMC article. Review. No abstract available.
• Do published ADA studies support the ADA-EASD position statement for the management of hyperglycaemia in type 2 diabetics?
  Rimareix F, Bauduceau B. Rimareix F, et al. Ann Endocrinol (Paris). 2013 Jul;74(3):207-10. doi: 10.1016/j.ando.2013.04.001. Epub 2013 Jun 6. Ann Endocrinol (Paris). 2013. PMID: 23747137
• Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
  Mannucci E, Monami M, Pala L, Cocca C, Cresci B, Bardini G, Masotti G, Marchionni N, Rotella CM. Mannucci E, et al. Diabetes Care. 2007 Jan;30(1):193-4. doi: 10.2337/dc06-2060. Diabetes Care. 2007. PMID: 17192373 No abstract available.
• Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
  Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B; Professional Practice Committee, American Diabetes Association; European Association for the Study of Diabetes. Nathan DM, et al. Diabetologia. 2006 Aug;49(8):1711-21. doi: 10.1007/s00125-006-0316-2. Diabetologia. 2006. PMID: 16802130 No abstract available.

Cited by

• Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response.
  Kirtipal N, Seo Y, Son J, Lee S. Kirtipal N, et al. Diabetes Metab J. 2024 Sep;48(5):821-836. doi: 10.4093/dmj.2024.0382. Epub 2024 Sep 12. Diabetes Metab J. 2024. PMID: 39313228 Free PMC article. Review.
• Mathurameha ameliorates cardiovascular complications in high-fat diet/low-dose streptozotocin-induced type 2 diabetic rats: insights from histological and proteomic analysis.
  Somsuan K, Aluksanasuwan S, Woottisin S, Chiangjong W, Wanta A, Munkong N, Jaidee W, Praman S, Fuangfoo K, Morchang A, Kamsrijai U, Woottisin N, Rujanapun N, Charoensup R. Somsuan K, et al. J Mol Histol. 2024 Dec;55(6):1177-1197. doi: 10.1007/s10735-024-10258-6. Epub 2024 Sep 4. J Mol Histol. 2024. PMID: 39227510
• Long-term effects of a telemedically-assisted lifestyle intervention on glycemic control in patients with type 2 diabetes - A two-armed randomised controlled trial in Germany.
  Dunkel A, von Storch K, Hochheim M, Zank S, Polidori MC, Woopen C. Dunkel A, et al. J Diabetes Metab Disord. 2023 Oct 25;23(1):519-532. doi: 10.1007/s40200-023-01290-6. eCollection 2024 Jun. J Diabetes Metab Disord. 2023. PMID: 38932898 Free PMC article.
• In Vitro and Molecular Docking Evaluation of the Anticholinesterase and Antidiabetic Effects of Compounds from Terminalia macroptera Guill. & Perr. (Combretaceae).
  Feunaing RT, Tamfu AN, Gbaweng AJY, Kucukaydin S, Tchamgoue J, Lannang AM, Lenta BN, Kouam SF, Duru ME, Anouar EH, Talla E, Dinica RM. Feunaing RT, et al. Molecules. 2024 May 23;29(11):2456. doi: 10.3390/molecules29112456. Molecules. 2024. PMID: 38893333 Free PMC article.
• The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol.
  Novodvorský P, Thieme L, Laňková I, Mráz M, Taybani ZJ, Bótyik B, Stella P, Vytasil M, Lauand F, Bonnemaire M, Haluzík M. Novodvorský P, et al. Diabetes Ther. 2024 Jun;15(6):1461-1471. doi: 10.1007/s13300-024-01582-x. Epub 2024 Apr 24. Diabetes Ther. 2024. PMID: 38653903 Free PMC article.

References

1. 1. Diabetes Care. 1995 Jun;18(6):747-53 - PubMed
2. 1. Mayo Clin Proc. 2010 Dec;85(12 Suppl):S27-37 - PubMed
3. 1. Ann Intern Med. 2011 Apr 19;154(8):554-9 - PubMed
4. 1. J Clin Endocrinol Metab. 2010 Apr;95(4):1566-74 - PubMed
5. 1. N Engl J Med. 2011 Mar 3;364(9):818-28 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program